Bionyra Pharma is a startup based in France, most recent round Series A.
Based in France, Bionyra Pharma is a startup. Its most recent tracked round is Series A.
Bionyra Pharma is a clinical-stage biopharmaceutical company based in Paris developing next-generation monoclonal and multispecific antibody therapeutics, including half-life extension engineering, to treat severe immune-mediated inflammatory diseases. Its pipeline comprises clinical- and IND-stage biologics for inflammatory and immune-mediated conditions.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.